CAROLINE LOPEZ: Open Payments
NPI 1295434454 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 56 payments from 20 companies in 2025. Trend: 2023 $908 · 2024 $1,320 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $218 |
| Lilly USA, LLC | 13 | $173 |
| Dexcom, Inc. | 5 | $107 |
| Astellas Pharma US Inc | 4 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $76 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| PFIZER INC. | 2 | $49 |
| ABBVIE INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $39 |
Products named: BREZTRI, Dexcom G6 Transmitter, MOUNJARO, Veozah, Kerendia, XIFAXAN, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
